Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH)

About the company

Spring Bank Pharmaceuticals, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

30

$0.00M

Total Revenue

30

Employees

$22.40M

Market Capitalization

-0.86

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 391056.16 82729.00 6.28 22.79 20.75
Pfizer Inc. PFE 198619.60 50660.00 3.01 12.57 31.17
Merck & Co., Inc. MRK 196889.19 48081.00 7.39 19.43 21.10
Eli Lilly & Co. LLY 149964.48 23087.00 50.89 26.43 23.97
AbbVie, Inc. ABBV 143695.72 34057.00 -23.00 17.14 24.65
Bristol Myers Squibb Co. BMY 107221.81 31006.00 2.60 91.16 3.08
Repligen Corp. RGEN 6248.01 286.00 5.99 272.24 8.11
Reata Pharmaceuticals, Inc. RETA 4786.40 20.00 22.67 -15.39 -150.30
Nektar Therapeutics NKTR 4229.28 137.00 3.30 -9.21 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3862.82 1.00 35.71 -5.91 None
Allakos, Inc. ALLK 3177.20 None 6.90 -33.97 None
OPKO Health, Inc. OPK 2448.18 891.00 1.74 -8.37 -32.92
Karuna Therapeutics, Inc. KRTX 2343.38 None 6.12 -57.78 None
ADC Therapeutics SA ADCT 2338.74 2.00 27.59 -20.05 None
Turning Point Therapeutics, Inc. TPTX 2173.68 None 6.54 -18.19 None
Apellis Pharmaceuticals, Inc. APLS 2141.70 None 9.46 -5.13 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
IGM Biosciences, Inc. IGMS 2038.87 None 8.98 -37.58 None
Principia Biopharma, Inc. PRNB 1752.24 30.00 6.24 -24.93 -242.01
Springworks Therapeutics, Inc. SWTX 1554.02 None 5.05 -24.92 None
Y-mAbs Therapeutics, Inc. YMAB 1436.71 None 8.80 -15.59 None
Zymeworks, Inc. ZYME 1393.98 26.00 2.89 -8.22 -629.37
Tricida, Inc. TCDA 1263.22 None 6.49 -5.98 None
Akcea Therapeutics, Inc. AKCA 1232.87 341.00 2.53 -43.83 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1223.75 None 6.34 -10.11 None
Akero Therapeutics, Inc. AKRO 1092.43 None 9.12 -21.53 None
Odonate Therapeutics, Inc. ODT 1084.89 None 8.89 -9.64 None
Phibro Animal Health Corp. PAHC 1039.35 818.00 5.25 28.17 4.49
Arcutis Biotherapeutics, Inc. ARQT 1020.09 None 4.35 -16.31 None
Athenex, Inc. ATNX 971.88 123.00 5.96 -9.03 -87.86
Constellation Pharmaceuticals, Inc. CNST 906.88 None 4.27 -9.77 None
Gossamer Bio, Inc. GOSS 774.70 None 3.14 -3.90 None
G1 Therapeutics, Inc. GTHX 763.80 1.00 3.31 -5.83 None
Phathom Pharmaceuticals, Inc. PHAT 735.75 None 4.08 -2.70 None
Quanterix Corp. QTRX 726.84 60.00 6.41 -16.62 -71.52
Krystal Biotech, Inc. KRYS 695.98 None 4.06 -33.56 None
Oric Pharmaceuticals, Inc. ORIC 680.40 None -7.39 -22.50 None
Amneal Pharmaceuticals, Inc. AMRX 672.67 1679.00 4.63 -3.09 -11.85
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Arcturus Therapeutics Holdings, Inc. ARCT 655.98 19.00 60.80 -23.58 -151.34
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Aprea Therapeutics, Inc. APRE 617.82 None 5.47 -18.27 None
Applied Therapeutics, Inc. APLT 617.54 14.00 3.99 -12.53 -19.41
Keros Therapeutics, Inc. KROS 596.88 8.00 -26.96 -28.10 -285.35
Oyster Point Pharma, Inc. OYST 513.24 None 5.16 -8.92 None
Mirum Pharmaceuticals, Inc. MIRM 465.50 None 3.03 -6.87 None
SIGA Technologies, Inc. SIGA 460.84 19.00 5.16 -23.42 -94.00
89bio, Inc. ETNB 444.50 None 5.48 -6.89 None
Biospecifics Technologies Corp. BSTC 441.21 40.00 3.58 18.87 61.80
Fulcrum Therapeutics, Inc. FULC 423.89 1.00 7.14 -6.14 None
Satsuma Pharmaceuticals, Inc. STSA 417.01 None 4.10 -11.46 None
Osmotica Pharmaceuticals Plc OSMT 416.88 232.00 3.16 -1.52 -115.44
DURECT Corp. DRRX 390.60 28.00 30.00 -16.15 -82.94
Relmada Therapeutics, Inc. RLMD 380.97 0.00 5.68 -31.83 -877.66
Imara, Inc. IMRA 375.70 None 3.63 -10.68 None
TCR2 Therapeutics, Inc. TCRR 368.88 None 2.52 -36.60 None
Crinetics Pharmaceuticals, Inc. CRNX 366.96 1.00 4.63 -6.29 -447.78
Kala Pharmaceuticals, Inc. KALA 365.76 6.00 4.00 -3.98 None
Ocular Therapeutix, Inc. OCUL 356.16 6.00 -43.65 -3.88 None
Ovid Therapeutics, Inc. OVID 336.15 None 7.95 -5.15 None
Aeglea Biotherapeutics, Inc. AGLE 292.05 4.00 9.22 -3.64 -523.27
IDEAYA Biosciences, Inc. IDYA 283.40 None 4.31 -6.50 None
Urovant Sciences Ltd. UROV 276.00 None -4.89 -1.91 None
HOOKIPA Pharma, Inc. HOOK 250.12 13.00 2.26 -5.53 -333.02
AMAG Pharmaceuticals, Inc. AMAG 246.84 321.00 0.94 -0.67 -115.05
Spero Therapeutics, Inc. SPRO 242.63 12.00 3.19 -2.98 -656.72
Verrica Pharmaceuticals, Inc. VRCA 220.00 None 4.02 -7.21 None
Lannett Co., Inc. LCI 218.12 542.00 0.75 -7.17 -5.77
Sutro Biopharma, Inc. STRO 207.46 41.00 3.94 -3.40 -148.06
KalVista Pharmaceuticals, Inc. KALV 207.00 13.00 2.45 -7.01 -229.44
Kaleido Biosciences, Inc. KLDO 202.80 None 7.19 -2.77 None
Veru, Inc. VERU 198.90 39.00 6.65 -20.40 -25.53
Galera Therapeutics, Inc. GRTX 183.75 None 3.43 -2.79 None
LogicBio Therapeutics, Inc. LOGC 177.79 1.00 5.37 -4.18 None
Protara Therapeutics, Inc. TARA 153.54 None 2.31 -9.96 None
Liquidia Technologies, Inc. LQDA 152.57 8.00 11.96 -3.10 -602.17
Avenue Therapeutics, Inc. ATXI 149.92 532.00 27.56 -10.30 26.69
Gritstone Oncology, Inc. GRTS 144.72 4.00 1.30 -1.39 None
scPharmaceuticals, Inc. SCPH 139.08 119.00 3.55 -4.44 -27.05
Lyra Therapeutics, Inc. LYRA 138.12 1.00 -1.17 -8.28 -491.16
PhaseBio Pharmaceuticals, Inc. PHAS 137.17 2.00 2.54 -2.87 None
Tyme Technologies, Inc. TYME 136.85 None 7.93 -6.26 None
Evelo Biosciences, Inc. EVLO 132.80 None 4.88 -1.51 None
Ayala Pharmaceuticals, Inc. AYLA 132.48 3.00 -3.12 -6.42 -679.19
Harrow Health, Inc. HROW 130.26 51.00 8.35 -5.27 -47.54
TFF Pharmaceuticals, Inc. TFFP 127.11 None 4.92 -3.28 None
Cyclerion Therapeutics, Inc. CYCN 125.28 6.00 1.58 -1.21 None
Mustang Bio, Inc. MBIO 120.40 None 2.81 -2.45 None
Aquestive Therapeutics, Inc. AQST 120.12 49.00 -6.92 -1.71 -139.64
Corvus Pharmaceuticals, Inc. CRVS 118.90 None 1.91 -2.52 None
Immunic, Inc. IMUX 118.50 None 3.49 -53.86 None
NeuBase Therapeutics, Inc. NBSE 116.06 None 48.76 -2.60 None
Evolus, Inc. EOLS 91.80 45.00 1.65 -0.91 -217.51
Eton Pharmaceuticals, Inc. ETON 89.28 1.00 9.73 -4.47 None
Trevi Therapeutics, Inc. TRVI 88.56 None 1.88 -3.02 None
Milestone Pharmaceuticals, Inc. MIST 88.00 None 0.87 -1.41 None
EyePoint Pharmaceuticals, Inc. EYPT 77.97 26.00 5.50 -1.59 -196.30
Xeris Pharmaceuticals, Inc. XERS 76.72 4.00 3.81 -0.59 None
Clearside Biomedical, Inc. CLSD 71.34 6.00 9.16 -4.05 -293.61
Aridis Pharmaceuticals, Inc. ARDS 67.05 1.00 -27.59 -2.29 -851.00
Navidea Biopharmaceuticals, Inc. NAVB 64.77 1.00 -47.62 -5.86 -65.13
Checkpoint Therapeutics, Inc. CKPT 64.60 2.00 5.57 -2.78 -949.53
Baudax Bio, Inc. BXRX 63.54 None -1.73 -0.91 None
Genprex, Inc. GNPX 59.09 None 5.02 -4.32 None
BiomX, Inc. PHGE 58.74 None 1.55 -1.37 None
Assertio Therapeutics, Inc. ASRT 58.64 192.00 1.02 -0.36 -83.99
Aerpio Pharmaceuticals, Inc. ARPO 49.20 20.00 1.48 -2.61 -51.58
Menlo Therapeutics, Inc. MNLO 48.43 2.00 4.07 -0.52 -483.51
Annovis Bio, Inc. ANVS 42.28 None 3.87 -33.56 None
Eyenovia, Inc. EYEN 42.24 None 4.26 -2.06 None
Edesa Biotech, Inc. EDSA 41.85 0.00 5.96 -0.44 -395.23
Moleculin Biotech, Inc. MBRX 39.38 None 3.42 -4.28 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Adamis Pharmaceuticals Corp. ADMP 35.44 22.00 1.36 -1.20 -140.33
Acer Therapeutics, Inc. ACER 35.00 3.00 2.55 -1.34 -274.69
AgeX Therapeutics, Inc. AGE 34.83 2.00 -45.84 -2.86 -658.11
Mannatech, Inc. MTEX 34.80 156.00 1.47 7.84 3.45
Citius Pharmaceuticals, Inc. CTXR 33.21 None 2.46 -1.92 None
Allena Pharmaceuticals, Inc. ALNA 32.20 None 4.24 -0.74 None
Oncternal Therapeutics, Inc. ONCT 28.99 3.00 3.72 -1.15 -225.89
CNS Pharmaceuticals, Inc. CNSP 27.04 None 4.69 -4.97 None
Hoth Therapeutics, Inc. HOTH 25.10 None 6.97 -2.79 None
Aileron Therapeutics, Inc. ALRN 24.60 None 3.51 -0.92 None
Millendo Therapeutics, Inc. MLND 24.15 0.00 0.57 -0.52 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Spring Bank Pharmaceuticals, Inc. SBPH 22.40 0.00 0.85 -0.86 None
ProPhase Labs, Inc. PRPH 19.08 9.00 1.73 -6.36 -31.15
Daré Bioscience, Inc. DARE 18.91 1.00 8.29 -1.13 None
Adial Pharmaceuticals, Inc. ADIL 14.80 None 3.61 -1.95 None
Novan, Inc. NOVN 14.48 5.00 -3.33 -0.46 -602.34
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
PDS Biotechnology Corp. PDSB 14.14 None 1.57 -0.55 None
Titan Pharmaceuticals, Inc. TTNP 11.60 4.00 4.83 -0.64 -437.91
Novus Therapeutics, Inc. NVUS 7.74 None 0.66 -0.37 None
Brickell Biotech, Inc. BBI 4.50 5.00 1.48 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Spring Bank Pharmaceuticals Inc (SBPH.OQ)

6d ago, source: Reuters

Shares of Spring Bank Pharmaceuticals plummeted 26% on Wednesday after the company said it would end the development of an experimental drug to treat chronic hepatitis B virus, following the death ...

Hedge Funds Are Selling Spring Bank Pharmaceuticals, Inc. (SBPH)

1mon ago, source: Insider Monkey

In this article we will check out the progression of hedge fund sentiment towards Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) and determine whether it is a good investment right now.

Spring Bank Advances IV SB 11285 Clinical Program

1mon ago, source: YAHOO!

HOPKINTON, Mass., June 03, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory ...

Spring Bank to Present at the Jefferies Virtual Global Healthcare Conference

1mon ago, source: YAHOO!

HOPKINTON, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...

Spring Bank Provides Update on Business Operations & Clinical Program Progress During COVID-19 Pandemic

19d ago, source: Bio IT World

About Spring Bank Pharmaceuticals Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its ...

Spring Bank Pharmaceuticals Inc

1mon ago, source: U.S. News & World Report

Spring Bank Pharmaceuticals, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform.

Spring Bank to Present at the Jefferies Virtual Global Healthcare Conference

1mon ago, source: GlobeNewswire

May 26, 2020 16:30 ET | Source: Spring Bank Pharmaceuticals, Inc. HOPKINTON, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.